06:12:37 EDT Sun 04 Jun 2023
Enter Symbol
or Name

Login ID:
Doseology Sciences Inc
Symbol MOOD
Shares Issued 41,100,300
Close 2022-06-01 C$ 0.075
Recent Sedar Documents

Doseology Sciences receives OK for OTC Pink listing

2022-06-01 16:08 ET - News Release

Mr. Ralph Olson reports


Doseology Sciences Inc.'s common shares were approved for trading on the OTC Pink open market in the United States under the symbol DOSEF. The shares will continue to trade on the Canadian Securities Exchange under the symbol MOOD and on the Frankfurt Stock Exchange under the symbol VU7. The company has also applied to uplist its shares from the Pink open market to the OTCQB market in the United States.

The company is pleased to announce that the shares have been approved for eligibility for book-entry and depository services through the Depository Trust Company (DTC) in the United States, which will facilitate electronic clearing and settlement of transfers of the shares.

DTC is a subsidiary of the Depository Trust & Clearing Corp., a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered DTC eligible. With an accelerated settlement period and reduced costs for investors and brokers, DTC eligibility is expected to simplify the process of trading and enhance liquidity of the company's shares in the United States.

Ralph Olson, chief executive officer of the company, stated: "We are pleased to have obtained our dual USA listing and DTC eligibility. This eligibility will simplify the process of trading shares in the USA, which will be beneficial to Doseology and our shareholders. With DTC eligibility, the increased accessibility and visibility is expected to attract greater investment and trading liquidity from American investors as our shares will be available to a broader range of investors as we continue to expand our business."

About Doseology Sciences Inc.

Doseology Sciences is building a progressive brand focused on mental health and wellness through cultivation, extraction and innovative nutraceutical and pharmaceutical products. Doseology aims to make a meaningful impact on the mental health pandemic by utilizing and developing psychedelic and non-psychedelic compounds within the functional fungi and plant-derived drug markets. With a vertically integrated approach, Doseology intends to process and distribute products at its facilities in Vernon, B.C., in accordance with applicable laws to ensure safe and high-quality production. Doseology's medicinal mushroom products, including tinctures, powders and supplements, are available on the company's website.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.